[ad_1]
A third drug was administered to President Donald Trump during treatment for COVID-19, White House physician Sean Conley said Sunday. It is dexamethasone, a steroid used for decades to reduce inflammation in conditions such as arthritis, but also pneumonia and other respiratory conditions.
The WHO also recommends dexamethasone in the treatment of COVID, after studies in the United Kingdom demonstrated its effectiveness in reducing the death rate among patients most severely affected by COVID-19.
So far, the president has received a single dose of an experimental new monoclonal antibody-based drug, developed by Regeneron, and has already received two doses of Remdesivir, an antiviral drug used to treat COVID. You were given a first dose of dexamethasone on Saturday and Remdesivir treatment will continue for another three days (five doses in total).
Dr. Sean Conley said Donald Trump’s condition continues to improve, but as with any illness, there are oscillating developments, with “frequent ups and downs.”
On the other hand, Donald Trump’s doctor said that the president had two episodes of decreased oxygen saturation starting Thursday, and that led the team to switch to dexamethasone. In one episode, saturation fell below 94 percent, in the other it was below 93 percent, and Dr. Sean Conley recommended, on Friday morning, when Donald Trump also had a fever, that the president receive oxygen. additional.
However, President Donald Trump could be discharged on Monday and will continue his treatment at the White House. Currently, the president has an oxygen saturation level of 98 percent, the doctor said.
“Today he feels good, up and active,” said Brian Garibaldi, one of the doctors treating Donald Trump. “Our goal for this day is to get him to eat, hydrate and stand up so he can move and feel good,” she said. “Our hope is to discharge tomorrow and continue treatment at the White House,” added Dr. Garibaldi.
Editor: Luana Pavaluca
